Pediatric pulmonary veno-occlusive disease associated with a novel BMPR2 variant.
Wataru TakemoriKenichiro YamamuraYoshitaka TomitaNaoki EgamiKatsuhide EguchiHazumu NagataHiromitsu ShirouzuYuichi IshikawaDaisuke NakajimaAkihiko YoshizawaHiroshi DateShouichi OhgaPublished in: Pediatric pulmonology (2022)
Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) cause progressive PH on the distinct genetic impact. A 29-month-old boy presented with a loss of consciousness. He had severe PH refractory to pulmonary vasodilators. Hypoxemia and ground-glass opacity on the chest computed tomography were present, and significant pulmonary edema developed after the introduction of continuous intravenous prostaglandin I 2 . Based on the clinical diagnosis of PVOD, he underwent a single living-donor lobar lung transplantation with the right lower lobe of his mother. The pathological findings of his explanted lung showed intimal thickening and luminal narrowing of the pulmonary vein. A genetic test revealed a novel heterozygous splice acceptor variant (c.77-2A>C) in BMPR2, which is typically associated with I/HPAH. This is the first pediatric case of PVOD with BMPR2 variant, supporting the concept that I/HPAH and PVOD are part of a spectrum of pulmonary vascular disease.
Keyphrases
- pulmonary arterial hypertension
- pulmonary hypertension
- pulmonary artery
- extracorporeal membrane oxygenation
- computed tomography
- multiple sclerosis
- early onset
- high dose
- genome wide
- magnetic resonance imaging
- copy number
- gene expression
- coronary artery
- positron emission tomography
- single cell
- magnetic resonance
- dna methylation
- childhood cancer